DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Issue 03 · Volume 28 · 2002 DOI: 10.1055/s-002-2043 Recombinant Factor VIII Products and Hemophilia A: Efficacy, Safety, and Inhibitor Development Editor in Chief Eberhard F. Mammen M.D.,, Guest Editor Jan J. Michiels M.D. Ph.D.

  • C-1

    Continuing Medical Education

  • 241
    Lee, Christine:

    The Use of Recombinant Factor VIII Products in Previously Treated Patients with Hemophilia A: Pharmacokinetics, Efficacy, Safety, and Inhibitor Development

  • 247
    Barrowcliffe, Trevor W.; Raut, Sanjeev; Sands, Dawn; Hubbard, Anthony R.:

    Coagulation and Chromogenic Assays of Factor VIII Activity: General Aspects, Standardization, and Recommendations

  • 257
    Mikaelsson, Marianne; Oswaldsson, Ulla:

    Assaying the Circulating Factor VIII Activity in Hemophilia A Patients Treated with Recombinant Factor VIII Products

  • 265
    Saint-Remy, Jean-Marie R.:

    Immunology of Factor VIII Inhibitors

  • 269
    Brinkhous, Kenneth; Sandberg, Helena; Widlund, Lars; Read, Marjorie; Nichols, Timothy; Sigman, Jeffery; Oswaldsson, Ulla; Schaub, Robert G.; Mikaelsson, Marianne:

    Preclinical Pharmacology of Albumin-Free B-Domain Deleted Recombinant Factor VIII

  • 273
    Lusher, Jeanne M.:

    First and Second Generation Recombinant Factor VIII Concentrates in Previously Untreated Patients: Recovery, Safety, Efficacy, and Inhibitor Development

  • 277
    Suiter, Tobias M.:

    First and Next Generation Native rFVIII in the Treatment of Hemophilia A. What Has Been Achieved? Can Patients be Switched Safely?

  • 285
    Kreuz, Wolfhart; Ettingshausen, Carmen Escuriola; Zyschka, Alex; Oldenburg, Johannes; Saguer, Inmaculada Martinez; Ehrenforth, Silke; Klingebiel, Thomas:

    Inhibitor Development in Previously Untreated Patients with Hemophilia A: A Prospective Long-Term Follow-Up Comparing Plasma-Derived and Recombinant Products

  • 291
    Scandella, Dorothea:

    New Characteristics of Anti-Factor VIII Inhibitor Antibody Epitopes and Unusual Immune Responses to Factor VIII

  • 297
    Wikén, Margareta; Sjöberg, Katarina:

    Analysis of Samples from Patients Treated with ReFacto® for the Presence of Anti-SQ-Peptide Specific Antibodies

  • 309
    Klinge, Jens; Ananyeva, Natalya M.; Hauser, Charlotte A. E.; Saenko, Evgueni L.:

    Hemophilia A-From Basic Science to Clinical Practice

    • PREFACE

  • 239
    Mammen, Eberhard F.:

    Recombinant Factor VIII Products and Hemophilia A: Efficacy, Safety, and Inhibitor Development